source
- Venture capital continues to flow into biopharma in Q3 2026, favoring later-stage and AI-driven companiesVenture capital funding into biopharma topped $16 billion in the first half of 2026 and kept rising in the third quarter, according to industry sources. Investors remain selective, directing money…
- Utah health AI pilots face regulatory uncertainty as FDA scrutiny loomsUtah has launched an AI sandbox that allows health-focused artificial-intelligence projects to be tested in real-world settings. The initiative aims to accelerate innovation while monitoring safety…